Article

Decisive Conditions for Strategic Vaccination against SARS-CoV-2

2021-03-08

Abstract excerpt

While vaccines against SARS-CoV-2 are being administered, in most countries it may still take months until their supply can meet demand. The majority of available vaccines elicits strong immune responses when administered as prime-boost regimens. Since the immunological response to the first (“prime”) injection may provide already a substantial reduction in infectiousness and protection against severe disease, it...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: c2c8c047-5fab-584b-babc-278a4ec9ffa2
DOI: 10.1101/2021.03.05.21252962

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Decisive Conditions for Strategic Vaccination against SARS-CoV-2DOI 10.1101/2021.03.05.21252962Read

Epidemiological and evolutionary considerations of SARS-CoV-2 vaccine dosing regimes.Semantic proximity Read

Long term vaccination strategies to mitigate the impact of SARS-CoV-2 transmission: a modelling studySemantic proximity Read

Mechanistic model for booster doses effectiveness in healthy, cancer and immunosuppressed patients infected with SARS-CoV-2Semantic proximity Read

Long Term Vaccination Strategies to Mitigate the Global Impact of SARS-CoV-2 Transmission: A Modelling StudySemantic proximity Read

Impact of vaccination on SARS-CoV-2 transmission in the UK: a modelling studySemantic proximity Read

Deaths averted by vaccination due to reduced transmission can exceed those from direct protection of vaccinated individuals for SARS-CoV-2Semantic proximity Read

Reanalysis of the Pfizer mRNA BNT162b2 SARS-CoV-2 vaccine data fails to find any increased efficacy following the boost: Implications for vaccination policy and our understanding of the mode of actionSemantic proximity Read

Cost Effective Proactive Testing Strategies During COVID-19 Mass Vaccination: A Modelling StudySemantic proximity Read

Vaccination and Non-Pharmaceutical Interventions: When can the UK relax about COVID-19?Semantic proximity Read

A modeling-based approach to optimize COVID-19 vaccine dosing schedules for improved protectionSemantic proximity Read

The gray swan: model-based assessment of the risk of sudden failure of hybrid immunity to SARS-CoV-2Semantic proximity Read

Modelling optimal vaccination strategy for SARS-CoV-2 in the UKSemantic proximity Read